Cargando…
Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer
Minnelide/Triptolide (TL) has recently emerged as a potent anticancer drug in non-small cell lung cancer (NSCLC). However, the precise mechanism of its action remains ambiguous. In this study, we elucidated the molecular basis for TL-induced cell death in context to p53 status. Cell death was attrib...
Autores principales: | Kumar, Ajay, Corey, Catherine, Scott, Iain, Shiva, Sruti, D’Cunha, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976872/ https://www.ncbi.nlm.nih.gov/pubmed/27501149 http://dx.doi.org/10.1371/journal.pone.0160783 |
Ejemplares similares
-
Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma
por: Jacobson, Blake A., et al.
Publicado: (2015) -
Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo
por: Rousalova, Ilona, et al.
Publicado: (2013) -
Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015) -
Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019) -
Triptolide-induced apoptosis in non-small cell lung cancer via a novel miR204-5p/Caveolin-1/Akt-mediated pathway
por: Philips, Brian J., et al.
Publicado: (2020)